Publications

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.

ISHOLA, D; MANNO, D; AFOLABI, MO; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; BAIDEN, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; Gallagher, KE; Gaddah, A; ... EBL3001 study group,

2021

Lancet Infectious Diseases, (2021).22 1 10.1016/S1473-3099(21)00125-0.

Infection patterns of endemic human coronaviruses in rural households in coastal Kenya.

Nyaguthii, DM; Otieno, GP; Kombe, IK; Koech, D; Mutunga, M; MEDLEY, GF; Nokes, DJ; Munywoki, PK;

2021

Wellcome Open Research, (2021).6, 10.12688/wellcomeopenres.16508.1.

Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis.

PREM, K; Choi, YH; Bénard, É; Burger, E; Hadley, L; Laprise, J-F; Regan, MC; Drolet, M; Sy, S; Abbas, K; Portnoy, A; Kim, J; Brisson, M; JIT, M;

2021

medRxiv (2021). 10.1101/2021.02.08.21251186.

A regional suitable conditions index to forecast the impact of climate change on dengue vectorial capacity.

Davis, C; Murphy, AK; Bambrick, H; Devine, GJ; Frentiu, FD; YAKOB, L; Huang, X; Li, Z; Yang, W; Williams, G; Hu, W;

2021

Environmental research, (2021).195, 10.1016/j.envres.2021.110849.

The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories.

LIU, Y; Morgenstern, C; Kelly, J; LOWE, R; CMMID COVID-19 Working Group,; JIT, M;

2021

BMC Medicine, (2021).19 1 10.1186/s12916-020-01872-8.

Human, animal, water source interactions and leptospirosis in Thailand.

Narkkul, U; Thaipadungpanit, J; Srisawat, N; RUDGE, JW; Thongdee, M; Pawarana, R; Pan-Ngum, W;

2021

Scientific reports, (2021).11 1 10.1038/s41598-021-82290-5.

Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the US.

Cramer, E; Ray, E; Lopez, V; Bracher, J; Brennen, A; Castro§Rivadeneira, A; Gerding, A; Gneiting, T; House, K; Huang, Y; Jayawardena, D; Kanji, A; Khandelwal, A; Le, K; Mühlemann, A; Niemi, J; Shah, A; Stark, A; Wang, Y; Wattanachit, N; Zorn, M; Gu, Y; Jain, S; Bannur, N; Deva, A; ... Adee, M.

2021

medRxiv (2021). 10.1101/2021.02.03.21250974.

Using a household structured branching process to analyse contact tracing in the SARS-CoV-2 pandemic.

Fyles, M; Fearon, E; Overton, C; University of Manchester COVID-19 Working Group,; Wingfield, T; MEDLEY, G; Hall, I; Pellis, L; House, T;

2021

medRxiv (2021). 10.1101/2021.02.03.21250992.

The effectiveness of biosecurity interventions in reducing the transmission of bacteria from livestock to humans at the farm level: A systematic literature review.

Youssef, DM; Wieland, B; KNIGHT, GM; LINES, J; NAYLOR, NR;

2021

Zoonoses and public health, (2021).68 6 10.1111/zph.12807.

Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa.

BATH, D; COOK, J; Govere, J; Mathebula, P; Morris, N; Hlongwana, K; Raman, J; Seocharan, I; Zitha, A; Zitha, M; Mabuza, A; Mbokazi, F; Machaba, E; Mabunda, E; Jamesboy, E; BIGGS, J; DRAKELEY, C; Moonasar, D; Maharaj, R; Coetzee, M; PITT, C; KLEINSCHMIDT, I;

2021

Lancet, (2021).397 10276 10.1016/S0140-6736(21)00251-8.